101 results about "Motherisk" patented technology

A system and method for determining the genetic data for one or a small set of cells, or from fragmentary DNA, where a limited quantity of genetic data is available, are disclosed. Genetic data for the target individual is acquired and amplified using known methods, and poorly measured base pairs, missing alleles and missing regions are reconstructed using expected similarities between the target genome and the genome of genetically related subjects. In accordance with one embodiment of the invention incomplete genetic data is acquired from embryonic cells, fetal cells, or cell-free fetal DNA isolated from the mother's blood, and the incomplete genetic data is reconstructed using the more complete genetic data from a larger sample diploid cells from one or both parents, with or without genetic data from haploid cells from one or both parents, and / or genetic data taken from other related individuals.

The present disclosure provides methods for determining the ploidy status of a chromosome in a gestating fetus from genotypic data measured from a mixed sample of DNA comprising DNA from both the mother of the fetus and from the fetus, and optionally from genotypic data from the mother and father. The ploidy state is determined by using a joint distribution model to create a plurality of expected allele distributions for different possible fetal ploidy states given the parental genotypic data, and comparing the expected allelic distributions to the pattern of measured allelic distributions measured in the mixed sample, and choosing the ploidy state whose expected allelic distribution pattern most closely matches the observed allelic distribution pattern. The mixed sample of DNA may be preferentially enriched at a plurality of polymorphic loci in a way that minimizes the allelic bias, for example using massively multiplexed targeted PCR.

The present invention relates to new methods for diagnosing a pregnancy-associated disorder by analyzing fetal DNA present in the mother's blood. More specifically, this invention relies on the discovery that the maspin gene is differentially methylated in fetal DNA and in maternal DNA and provides these new diagnostic methods, which distinguish fetal DNA from maternal DNA and detect prenatal disorders based on abnormalities in fetal DNA level and methylation status.

The present invention provides a method, device and a computer program for haplotyping single cells, such that a sample taken from a pregnant female, without directly sampling the fetus, provides the ability to non-invasively determine the fetal genome. The method can be performed by determining the parental and inherited haplotypes, or can be performed merely on the basis of the mother's genetic information, obtained preferably in a blood or serum sample. The novel device allows for sequence analysis of single chromosomes from a single cell, preferably by partitioning single chromosomes from a metaphase cell into long, thin channels where a sequence analysis can be performed.

Disclosed herein are methods for determining the copy number of a chromosome in a fetus in the context of non-invasive prenatal diagnosis. In an embodiment, the measured genetic data from a sample of genetic material that contains both fetal DNA and maternal DNA is analyzed, along with the genetic data from the biological parents of the fetus, and the copy number of the chromosome of interest is determined. In an embodiment, the maternal serum is measured using a single-nucleotide polymorphism (SNP) microarray, along with parental genomic data, and the determination of the chromosome copy number is used to make clinical decisions pertaining to the fetus.

The present invention relates to a method for analysing and treating human milk to be fed to an infant comprising the steps of collecting own mother's milk, taking a sample of the collected own mother's milk, conducting nutritional analysis on said sample, using the collected own mother's milk as nutrition for the infant and using the collected own mother's milk in the form of at least one of the group of: unchanged own mother's milk, fortified own mother's milk, unchanged components of own mother's milk and fortified components of own mother's milk, wherein said form is chosen depending on at least some of said results of the analysis and said infant's condition, the infants condition being chosen from at least one of the following parameters: infant's age, infant's weight, infant's health, infant's shortcomings, infant's deficiencies, time of day when the milk is fed to the infant.

Methods, apparatuses, and system are provided for analyzing a maternal sample to determine whether a male fetus of a pregnant female has inherited an X-linked mutation from the mother. A percentage of fetal DNA in the sample is obtained, and cutoff values for the two possibilities (fetus inherits mutant or normal allele) are determined. A proportion of mutant alleles relative to a normal allele on the X-chromosome can then be compared to the cutoff values to make a classification of which allele is inherited. Alternatively, a number of alleles from a target region on the X-chromosome can be compared to a number of alleles from a reference region on the X-chromosome to identify a deletion or amplification. The fetal DNA percentage can be computed by counting reactions with a fetal-specific allele, and correcting the number to account for a statistical distribution among the reactions.

High throughput sequencing has facilitated a precipitous drop in the cost of whole genome human DNA sequencing, prompting predictions of a revolution in medicine via personalization of diagnostic and therapeutic strategies to individual genetics. Disclosed is a comprehensive series of methods for identification of genetic variants and medical genotypes, phasing genetic data and using Mendelian inheritance for quality control, and providing predictive genetic information about risk for rare disease phenotypes and response to pharmacological therapy in single individuals and father-mother-child trios.

Disclosed are methods for determining at least one sequence of interest of a fetus of a pregnant mother. In various embodiments, the method can determine one or more sequences of interest in a test sample that comprises a mixture of fetal cellular DNA and mother-and-fetus cfDNA. In some embodiments, methods are provided for determining whether the fetus has a genetic disease. In some embodiments, methods are provided for determining whether the fetus is homozygous in a disease causing allele when the mother is heterozygous of the same allele. In some embodiments, methods are provided for determining whether the fetus has a copy number variation (CNV) or a non-CNV genetic sequence anomaly.

A system for assessing and monitoring a fetal electrocardiogram (ECG) and heart rate in a pregnant mother comprises wearable mechanical-electronic sensors, e.g., embedded in a wrist or arm band, which can measure mechanical pulse signals from the mother, and an abdomen patch which can measure the combined ECG signals of the fetus and mother. In another embodiment, the sensors in the wrist or arm band measure the combined fetal / maternal ECG signals, and the mother's mechanical pulse signals. By signal processing and gating out the maternal ECG signals as correlated with the mechanical maternal pulse signals, the fetal ECG and heart rate can be measured and monitored. These measurements may be displayed on the wrist or arm band device, or wirelessly through a remote device, mobile phone or computer. Sensors in the abdominal patch may also measure uterine electromyogram, uterine contractions, and fetal movements, to be correlated with the fetal ECG.

The invention relates to a control system and method for achieving mother and infant safety management through automatic pairing, and relates to the technical field of infant theft prevention. The control system comprises an infant bracelet, a mother bracelet and a nurse bracelet, wherein the infant bracelet is provided with a first transceiving module, a first sensor and a control module; the mother bracelet is provided with a second transceiving module, and the second transceiving module further comprises a first integrated voice chip; the nurse bracelet is provided with a third transceiving module; the third transceiving module further comprises a second integrated voice chip; the first sensor is used for acquiring real-time position information of the infant bracelet; and the control module is used for controlling the first transceiving module according to the real-time position information collected by the first sensor so as to send the real-time position information to the second transceiving module and the third transceiving module. According to the control system and method provided by the invention, the phenomenon that the infant is taken by mistake can be avoided.

The invention relates to a breast pump with a data acquisition function and a breast pumping data statistical management method. According to the invention, a controller is installed in a main machineand connected with a pumping motor and an electronic negative-pressure measuring instrument through wires; the pumping motor communicates with the electronic negative-pressure measuring instrument through a pipeline; the electronic negative-pressure measuring instrument communicates with a pumping pipeline through a pipeline; the controller is electrically connected with a first wireless transceiver and a timer which are arranged in the main machine through wires; a touch screen displayer is arranged at the outer side of the main machine and connected with the controller through a wire; and aliquid amount measuring device is arranged at the bottom part of a storage bottle body. Effective statistics is carried out on data like breast sucking frequency, time, sucking force, milk amount andbreast discomfort every time and even several weeks; milk secretion can be maintained; the milk amount can be increased; breast health in a lactation period can be protected; and the important guiding value and reference basis can be provided for mothers in the lactation period.